Armata Pharmaceuticals, Inc. 8-K

What Happened Armata Pharmaceuticals, Inc. filed an 8‑K announcing its 2026 annual meeting of stockholders will be held on June 11, 2026 at 8:30 a.m. Pacific Time at the company’s principal offices (5005 McConnell Avenue, Los Angeles, CA 90066). The company said the meeting time or location could be changed and will be reflected in the proxy statement. Armata filed that stockholders of record as of April 17, 2026 will be entitled to notice and to vote.

Key Details

• Annual Meeting date and time: June 11, 2026 at 8:30 a.m. PT.
• Record date for voting: close of business on April 17, 2026.
• Advance notice deadline for stockholder proposals and director nominations: April 12, 2026 at 5:00 p.m. PT. Proposals must be received in writing by the Corporate Secretary at Armata’s principal offices (5005 McConnell Avenue, Los Angeles, CA 90066).
• Proposals/nominations must comply with Armata’s Amended and Restated Bylaws and may be omitted if not in compliance.

Why It Matters This 8‑K provides the key dates investors need to vote or submit proposals for Armata’s proxy process. If you plan to vote, nominate a director, or submit a shareholder proposal, note the record date (April 17) and the earlier advance-notice receipt deadline (April 12) and follow the company’s bylaw requirements to ensure your items are considered.